EU Approves New L-Valine Feed Additive in Regulation 2025 756 Effective Immediately
On April 22, 2025, the European Commission officially adopted Regulation (EU) 2025/756, granting market authorization for L-valine produced by Escherichia coli CGMCC 22721 as a feed additive for all animal species. This decision falls under the scope of Regulation (EC) No 1831/2003, which governs additives in animal nutrition across the EU.
Under the conditions outlined in the annex, this L-valine product is authorized within a defined category of feed additives. It signifies a major regulatory green light for biotechnology-derived amino acids aimed at improving animal nutrition and feed efficiency.
The approval represents a strategic breakthrough for producers of amino acid supplements, opening up new opportunities across the European livestock and aquaculture sectors. This move also signals the EU’s continued support for scientifically backed, performance-enhancing feed solutions that meet stringent safety and efficacy standards.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
India Proposes New GMP Rules for Clinical Trial and API Manufacturing
-
U.S. Exempts Critical Chemical Manufacturers from Emissions Rules for Two Years
-
China Releases 15th Five-Year Carbon-Peaking Action Plan, Pushing Coal Chemicals into a Mandatory Low-Carbon Upgrade Cycle
-
FDA Color Policy Uncertainty Opens a New Chapter for Food Ingredient Reform
-
Bayer and Syngenta Score Consecutive Regulatory and Legal Wins in the U.S.
-
South Korea Expands Mandatory GMO Labeling to Highly Processed Foods
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Four Fine Chemical Units of Huajin Aramco Project – HDPE, EO/EG, etc. – Reach Mechanical Completion
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
MENA Pharmaceutical Regulatory Updates 2026: Key Compliance Changes for Global Pharma Companies
Recommend Reading
-
US Tariff Pressure on Canada Raises Risks for North American Chemical Supply Chains
-
FDA Fee Updates Raise the Cost of Entering the U.S. Generic Drug Chain
-
FDA Dye Pledges Push Natural Colors Into the Mainstream
-
Your Plant Has the Data. Your AI Cannot Reach It. Here Is Why That Is the Core Problem in Chemical Manufacturing.
-
EU Biocidal Data Protection Extension Raises the Stakes for Chemical Market Entry
-
This Week PVC Rises and Then Retreats, Supply and Demand Struggle Locks Up and Down Space
-
Supply-Demand Cost Game: Polyethylene Faces Volatile Pressure
-
Spot supply continues to be tight, acrylonitrile market shows a slight rebound
-
Business Society’s Market Outlook for Polyester Staple Fiber on August 21, 2026: Clearly Upward Trend
-
Business Society’s PTA Market Outlook on August 21, 2026: Volatile